Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: Lancet. 2010 Apr 14;375(9724):1437–1446. doi: 10.1016/S0140-6736(10)60172-9

Figure 3.

Figure 3

Time to progression.

A, PSA progression using the protocol definition of a 25% or greater rise from baseline;

B, PSA progression using the PCWG criterion of a 25% or greater rise from nadir;

C, Imaging.